State Street Corp cut its holdings in Cigna Group (NYSE:CI – Free Report) by 61.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,959,550 shares of the health services provider’s stock after selling 20,469,552 shares during the period. State Street Corp’s holdings in Cigna Group were worth $3,522,794,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. BlackRock Inc. boosted its position in shares of Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after acquiring an additional 840,098 shares in the last quarter. GQG Partners LLC purchased a new position in shares of Cigna Group in the 2nd quarter valued at about $1,628,918,000. Bank of America Corp DE increased its holdings in shares of Cigna Group by 8.8% in the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock valued at $848,821,000 after acquiring an additional 256,677 shares during the last quarter. Boston Partners increased its holdings in shares of Cigna Group by 17.9% in the 3rd quarter. Boston Partners now owns 2,374,437 shares of the health services provider’s stock valued at $645,467,000 after acquiring an additional 359,777 shares during the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of Cigna Group during the 2nd quarter worth about $542,779,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
Cigna Group Stock Performance
NYSE CI opened at $270.83 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a 1 year low of $257.85 and a 1 year high of $318.05. The company has a market capitalization of $71.36 billion, a PE ratio of 11.95, a P/E/G ratio of 1.01 and a beta of 0.25. The company has a fifty day moving average of $288.03 and a two-hundred day moving average of $282.99.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.52 by $0.46. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The company had revenue of $73.79 billion for the quarter, compared to analyst estimates of $72.64 billion. During the same quarter last year, the company posted $7.83 earnings per share. The business’s quarterly revenue was up 5.6% compared to the same quarter last year. As a group, analysts expect that Cigna Group will post 30.70 earnings per share for the current year.
Cigna Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be given a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio is 27.54%.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on CI. Evercore began coverage on Cigna Group in a research note on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price for the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Royal Bank Of Canada increased their price target on shares of Cigna Group from $337.00 to $346.00 and gave the company an “outperform” rating in a research note on Thursday. Barclays raised their price objective on shares of Cigna Group from $310.00 to $320.00 and gave the stock an “equal weight” rating in a report on Monday, November 9th. Finally, Guggenheim cut their price objective on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating on the stock in a report on Friday, November 6th. Fourteen research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $337.35.
Check Out Our Latest Analysis on Cigna Group
Key Stories Impacting Cigna Group
Here are a few of the latest stories about CI:
- Positive Sentiment: RBC maintained an Outperform rating and raised its price target to $346 from $337, citing Cigna’s third-quarter results and the developing 2027 outlook. RBC raises Cigna price target
- Neutral Sentiment: The Cigna Group Foundation announced $31.5 million in grants for community organizations across 10 states, supporting youth mental health, veterans, and people with complex health conditions. The announcement highlights community investment but provides no direct financial outlook update. Cigna Foundation grants
- Negative Sentiment: A proposed CMS rule would expand fraud oversight and reporting requirements across government health programs, raising regulatory and repayment concerns for managed-care stocks. Cigna sold its Medicare Advantage and Part D businesses in 2025, suggesting some of the pressure may reflect sector-wide sentiment rather than direct exposure. CMS rule and managed-care stocks
Insider Transactions at Cigna Group
In related news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.
Cigna Group Company Profile
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
Featured Stories
- Five stocks we like better than Cigna Group
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
